scholarly journals YLT192, a Novel, Orally Active Bioavailable Inhibitor of VEGFR2 Signaling with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models

2014 ◽  
Vol 4 (1) ◽  
Author(s):  
Yong Xia ◽  
Xuejiao Song ◽  
Deliang Li ◽  
Tinghong Ye ◽  
Youzhi Xu ◽  
...  
Keyword(s):  
Antitumor Efficacy ◽  
Preclinical Models ◽  
Antiangiogenic Activity ◽  
Vegfr2 Signaling ◽  
Orally Active

scholarly journals Combination Angiostatin and Endostatin Gene Transfer Induces Synergistic Antiangiogenic Activity in Vitro and Antitumor Efficacy in Leukemia and Solid Tumors in Mice

2001 ◽  
Vol 3 (2) ◽  
pp. 186-196 ◽  
Author(s):  
Frank A. Scappaticci ◽  
Richard Smith ◽  
Anjali Pathak ◽  
Derrick Schloss ◽  
Bert Lum ◽  
...  
Keyword(s):  
Gene Transfer ◽  
Solid Tumors ◽  
Antitumor Efficacy ◽  
Antiangiogenic Activity

scholarly journals Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models

2018 ◽  
Vol 24 (2) ◽  
pp. 194-202 ◽  
Author(s):  
Michael L Schulte ◽  
Allie Fu ◽  
Ping Zhao ◽  
Jun Li ◽  
Ling Geng ◽  
...  
Keyword(s):  
Antitumor Efficacy ◽  
Preclinical Models ◽  
Glutamine Transport ◽  
Pharmacological Blockade

scholarly journals #2714, a novel active inhibitor with potent G2/M phase arrest and antitumor efficacy in preclinical models

2018 ◽  
Vol 4 (1) ◽  
Author(s):  
Wen-Jie Lu ◽  
Wen Peng ◽  
Qian-Qian Sun ◽  
Yong-Huai Li ◽  
Bo Chen ◽  
...  
Keyword(s):  
Antitumor Efficacy ◽  
Preclinical Models ◽  
Active Inhibitor ◽  
Phase Arrest ◽  
M Phase
Sign in / Sign up

Export Citation Format

Share Document